You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 126 No. 4, April 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Clinical Trial Retrospective
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Cataracts/ Lens
 •Endophthalmitis
 •Vitreoretinal Surgery
 •Ophthalmological Procedures, Other
 •Articles for Residents
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Postcataract Extraction Endophthalmitis

A Summary of the Results From the Endophthalmitis Vitrectomy Study

Bernard H. Doft, MD

Arch Ophthalmol. 2008;126(4):554-556.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In the late 1980s, the value of pars plana vitrectomy (VIT) in the initial management of postcataract extraction-related endophthalmitis was unclear. Immediate VIT offered several theoretical advantages, but limited data from human case series had not shown that VIT conferred an advantage. In those reports, VIT had been reserved for eyes with the worst clinical manifestation. Because of severe selection bias in the reports, the role of pars plana VIT in the management of patients with endophthalmitis after cataract surgery remained uncertain.

While it was known that even the newer drugs given systemically did not reach sufficient intraocular concentrations to be effective against many common bacteria, most physicians were still administering intravenous antibiotics for postcataract-related endophthalmitis. In addition to the question of limited efficacy, their use added the risk of systemic toxicity and additional expense. While intravitreal injection of antimicrobial agents had become common for endophthalmitis, . . . [Full Text of this Article]

STUDY DESIGN


OUTCOME ASSESSMENT

RESULTS

CONCLUSIONS

AUTHOR INFORMATION
Author Affiliation: Retina Vitreous Consultants, Pittsburgh, Pennsylvania.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Acknowledgment of a Seminal Publication
Jules L. Baum
Arch Ophthalmol. 2008;126(12):1778.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Incidence and visual outcome of acute endophthalmitis after cataract surgery--the experience of an eye department in Scotland
Carrim et al.
Br J Ophthalmol 2009;93:721-725.
ABSTRACT | FULL TEXT  

Acknowledgment of a Seminal Publication
Baum
Arch Ophthalmol 2008;126:1778-1778.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.